All Infection Prevention & Control articles – Page 28
-
NewsYour genes may influence gut microbiome of others, rat study shows
New research, carried out by studying more than four thousand animals, reveals that the composition of the rat gut microbiome is shaped not only by an individual’s own genes but also by the genes of the individuals they share a living space with.
-
NewsSilent dengue infections may hold clues to future vaccine design, study finds
Researchers report the first single-cell immune atlas of asymptomatic dengue, offering a rare look at how the immune system can defeat the virus without triggering illness. The work could help guide the design of safer and more effective dengue vaccines.
-
NewsEvaluation of antiviral activity of organic–polyoxometalate hybrids based on berberine against encephalomyocarditis virus in vitro
A new study promotes the development of POM-based drugs for clinical application by controlling the organic cations on the surface of organic–POM hybrids, ultimately yielding new POM drugs with high efficiency and low toxicity.
-
News4 million euros for study with personalized phage therapy
UMC Utrecht has received a grant of 4 million euros for the first clinical study in the Netherlands involving a customized therapy with bacteriophages for patients with recurrent urinary tract infections.
-
CareersScientific Event Travel Grant: how the Safepork conference surpassed my expectations
Shan Goh from the University of Hertfordshire reports back on the International Symposium on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork held in Rennes, France, in October. Shan was supported with a Scientific Event Travel Grant awarded by AMI.
-
NewsNew one-two punch could knock out drug-resistant TB
Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving dual-drug strategies.
-
NewsA new way to diagnose deadly lung infections and save lives
Researchers have found a way to identify lung infections in critically ill patients by pairing a generative AI analysis of medical records with a biomarker of lower respiratory infections.
-
NewsNew method accelerates resistance testing in urinary tract infections
Researchers have developed two methods that allow urine samples to be tested directly for antibiotic susceptibility. Because the procedures do not require standardized bacterial suspensions, the time to result is reduced by up to 24 hours compared to conventional testing.
-
CareersCBCTA 2024 oral presentation winners: Isabella and Lia take home the honours
Letters in Applied Microbiology sponsored the best oral presentation award at the 29th Brazilian Congress of Food Science and Technology (CBCTA 2024). Winner Isabella Bassoto Xavier and runner-up Lia Mariano Aquino take a dive into their research.
-
NewsStudy uncovers new drug target for huge class of viruses
A study reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.
-
NewsOroya fever: Elucidation of disease mechanism opens possibility for novel therapy
An international research team has generated and analyzed more than 1,700 genetic variants of the pathogen that causes Oroya fever, identifying two proteins that Bartonella requires for the destruction of red blood cells.
-
NewsNew method means contaminated bathing water easier to detect
A new method can provide both faster and more complete answers on whether the water is safe for swimming or not. The innovation has been successfully tested in Helsingborg, where the response time has been reduced from several days to just a few hours.
-
NewsStrategic advancement of second-generation fungal vaccine VXV-01 through Phase 1 trials
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) have announced that the second-generation fungal vaccine candidate known as VXV‑01 is poised to move forward in development up to and including Phase 1 clinical evaluation.
-
NewsA testing paradox for sexually transmitted infections
Surveillance evidence shows an increase in people infected with other STIs after initiating PrEP. A new study provides a counterintuitive explanation revealing a testing paradox: even when the observed cases increase, the true numbers of STIs can decrease.
-
NewsModulating key interaction prevents virus from entering cells
Researchers have found a way to modulate a common virus protein to prevent viruses from entering cells where it can cause illness. They were able to find and block an important interaction at the molecular level that allows the herpes virus to enter cells.
-
NewsImmune system keeps mucosal fungi in check
Researchers investigating the mechanisms that keep the fungus under control on our mucosa shed light on how homeostasis is maintained through the fine-tuned interplay between Candida albicans and the epithelial barrier on the one hand, and the immune system on the other hand.
-
NewsStreptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability
Streptococcus suis serotype 2 (SS2) is an emerging zoonotic pathogen that causes meningitis in humans and pigs. Researchers have investigated the role and mechanism of the SS2 Clp in promoting the passage of the bacterium across the blood-brain barrier (BBB).
-
NewsHarmless Klebsiella strain shows powerful protection against gut infections in Inflammatory Bowel Disease (IBD) model
A new study demonstrates that a harmless strain of Klebsiella can eliminate infections and reduce gut inflammation in mouse models of inflammatory bowel disease (IBD).
-
NewsStudy links gut bacteria to bloodstream infections in newborns within sub-Saharan Africa for the first time
New research has shown gut and bloodstream infections are caused by the same bacteria giving hope of better prevention and diagnosis of deadly neonatal sepsis.
-
NewsCould hidden infections be fueling long COVID?
For millions suffering from long COVID, their persistent breathlessness, brain fog and fatigue remain a maddening mystery, but microbiologists think they may have cracked the case. The review argues that co-infections acquired before or during COVID could cause symptoms to persist indefinitely for many people.